Monday, December 23, 2024
HomeTagsCancer biotechnology company

cancer biotechnology company

Preclinical Data on Volastra Therapeutics’ Two Novel and Differentiated KIF18A Inhibitors Presented at AACR 2023

Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), released preclinical data from the company’s portfolio of KIF18A inhibitors at...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics